Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity

Acta Neurologica Scandinavica

Volumn 94, Issue 3, 1996, Pages 161-166

  Hillert, J ^a   Kall T ^a   Olerup, O ^a   Soderstrom M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Genetic susceptibility; HLA antigens; Multiple sclerosis; Optic neuritis

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC HETEROGENEITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OPTIC NERVE DISEASE;

EID: 0029739426     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb07047.x     Document Type: Article

References (27)

1. MORRISEY SP, MILLER DH, KENDALL BE, et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 1993: 116: 135-146.
2. LEE KH, HASHIMOTO SA, HOOGE JP, et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: A prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1991: 41: 657-660.
3. STENDAHL-BRODIN L, LINK H. Optic neuritis: Oligoclonal bands increase the risk of multiple sclerosis. Acta Neurol Scand 1983: 67: 301-304.
4. SANDBERG-WOLLHEIM M, BYNKE H, CRONQUIST S, HOLTÅS S, PLATZ P, RYDER LP. A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 1990: 27: 386-39.
5. SÖDERSTRÖM M, LINDQVIST M, HILLERT J, KÄLL TB, LINK H. Optic neuritis: Findings on MRI, CSF examination and HLA class II typing in 60 patients and results of a short-term follow-up. J Neurol 1994: 241: 391-397.
6. OLERUP O, HILLERT J. HLA class II-associated genetic susceptibility in multiple sclerosis: A critical evaluation. Tissue Antigens 1991: 38: 1-15.
7. ALLEN M, SANDBERG-WOLLHEIM M, SJÖGREN K, ERLICH HA, PETTERSON U, GYLLENSTEN U. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Human Immunol 1994: 39: 41-48.
8. RUNMARKER B, MARTINSSON T, WAHLSTRÖM J, ANDERSEN O. HLA and prognosis in multiple sclerosis. J Neurol 1994: 241: 385-390.
9. SPURKLAND A, RØNNINGEN KJ, VANDVIK B, THORSBY E, VARTDAL F. HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to multiple sclerosis. Hum Immunol 1991: 30: 69-75.
10. HILLERT J, GRÖNNING M, NYLAND H, LINK H, OLERUP O. An immunogenetic heterogeneity in multiple sclerosis. J Neurology, Neurosurgery and Psychiatry 1992: 55: 887-890.
11. FRANCIS DA, COMPSTON DAS, BATCHELOR JR, MCDONALD WI. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psych 1987: 50: 758-765.
12. SÖDERSTRÖM M. The clinical and paraclinical profile of optic neuritis: a prospective study. Ital. J Neurol sci 1995: 16: 167-176.
13. THOMSON G. HLA DR antigens and susceptibility to insulin-dependent diabetes mellitus. Am J Hum Genet 1984: 36: 1309-1317.
14. HELY MA, MCMANIS PG, DORAN TJ, WALSH JC, MCLEOD JG. Acute optic neuritis: a prospective study of risk factors for multiple sclerosis. J Neurol Neurosurg Psych 1986: 49: 1125-1130.
15. KELLY MA, CAVAN D, PENNY M, et al. The influence of HLA-DR or -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome. Human Immunol 1993: 37: 185-191.
16. KURTZKE JF. Optic neuritis or multiple sclerosis. Arch Neurol 1985: 42: 704-710.
17. KINNUNEN E. The incidence of optic neuritis and its prognosis for multiple sclerosis. Acta Neurol Scand 1983: 68: 371-377.
18. DUQUETTE P, DÉCARY F, PLEINES, et al. Clinical subgroups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression. Can J Neurol Sci 1985: 12: 106-110.
19. MADIGAND M, OGER JJ-F, FAUCHET P, SABOURAUD O, GENETET B. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes. J Neurol Sci 1982: 53: 519-529.
20. KRISS A, FRANCIS DA, CUENDET F, et al. Recovery after optic neuritis in childhood. J Neurol Neurosurg Pcych 1988: 51: 1253-1258.
21. RIZZO JF, LESSEL, S. Risk of developing multiple sclerosis after uncomplicated optic neuritis. A long-term prospective study. Neurology 1988: 38: 185-190.
22. KESSELRING J, MILLER DH, ROBB SA, et al. Acute disseminated encephalomyelitis. Brain 1990: 113: 291-302.
23. OLERUP O, HILLERT J, FREDRIKSON S, et al. Primarily chronic progressive and relapsing/remitting multiple sclerosis: Two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 1989: 86: 7113-7117.
24. FRANCIS DA, THOMPSON AJ, BROOKES P, et al. Multiple sclerosis and HLA: Is the susceptibility gene really HLA-DR or -DQ? Human Immunol 1991: 32: 119-124.
25. BECK RW, CLEARY PA, TROBE JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The optic neuritis study group. New Engl J Med 1993: 329: 1764-1769.
26. The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993: 43: 655-661.
27. FILIPPI M, HORSFIELD MA, MORRISEY SR et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 1994: 44: 635-641.